Literature DB >> 9336457

The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation.

R M Marión1, T Aragón, A Beloso, A Nieto, J Ortín.   

Abstract

A collection of C-terminal deletion mutants of the influenza A virus NS1 gene has been used to define the regions of the NS1 protein involved in its functionality. Immunofluorescence analyses showed that the NS1 protein sequences downstream from position 81 are not required for nuclear transport. The capacity of these mutants to bind RNA was studied by in vitro binding tests using a model vRNA probe. These experiments showed that the N-terminal 81 amino acids of NS1 protein are sufficient for RNA binding activity. The collection of mutants also served to map the NS1 sequences required for nuclear retention of mRNA and for stimulation of viral mRNA translation, using the NP gene as reporter. The results obtained indicated that the N-terminal 113 amino acids of NS1 protein are sufficient for nuclear retention of mRNA and stimulation of viral mRNA translation. The possibility that this region of the protein may be sufficient for virus viability is discussed in relation to the sequences of NS1 genes of field isolates and to the phenotype of known viral mutants affected in the NS1 gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9336457      PMCID: PMC147036          DOI: 10.1093/nar/25.21.4271

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  58 in total

1.  Specific binding of influenza A virus NS1 protein to the virus minus-sense RNA in vitro.

Authors:  E Hatada; T Takizawa; R Fukuda
Journal:  J Gen Virol       Date:  1992-01       Impact factor: 3.891

2.  Degradation of cellular mRNA during influenza virus infection: its possible role in protein synthesis shutoff.

Authors:  A Beloso; C Martínez; J Valcárcel; J F Santarén; J Ortín
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

3.  Transcription of a recombinant influenza virus RNA in cells that can express the influenza virus RNA polymerase and nucleoprotein genes.

Authors:  N Kimura; M Nishida; K Nagata; A Ishihama; K Oda; S Nakada
Journal:  J Gen Virol       Date:  1992-06       Impact factor: 3.891

4.  Molecular assembly of influenza virus: association of the NS2 protein with virion matrix.

Authors:  J Yasuda; S Nakada; A Kato; T Toyoda; A Ishihama
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

5.  The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A).

Authors:  Y Qiu; R M Krug
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

6.  Influenza virus NS1 protein stimulates translation of the M1 protein.

Authors:  K Enami; T A Sato; S Nakada; M Enami
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Splicing of influenza virus matrix protein mRNA expressed from a simian virus 40 recombinant.

Authors:  J Valcárcel; P Fortes; J Ortín
Journal:  J Gen Virol       Date:  1993-07       Impact factor: 3.891

8.  Influenza virus naked RNA can be expressed upon transfection into cells co-expressing the three subunits of the polymerase and the nucleoprotein from simian virus 40 recombinant viruses.

Authors:  S de la Luna; J Martín; A Portela; J Ortín
Journal:  J Gen Virol       Date:  1993-03       Impact factor: 3.891

9.  A new cationic liposome reagent mediating nearly quantitative transfection of animal cells.

Authors:  J K Rose; L Buonocore; M A Whitt
Journal:  Biotechniques       Date:  1991-04       Impact factor: 1.993

10.  Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport.

Authors:  P Fortes; A Beloso; J Ortín
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

View more
  34 in total

1.  Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export.

Authors:  L L Poon; E Fodor; G G Brownlee
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  A human sequence homologue of Staufen is an RNA-binding protein that is associated with polysomes and localizes to the rough endoplasmic reticulum.

Authors:  R M Marión; P Fortes; A Beloso; C Dotti; J Ortín
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 3.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

4.  Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity.

Authors:  T Zürcher; R M Marión; J Ortín
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus.

Authors:  T Aragón; S de la Luna; I Novoa; L Carrasco; J Ortín; A Nieto
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication.

Authors:  Susana de Lucas; Joan Peredo; Rosa María Marión; Carmen Sánchez; Juan Ortín
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

7.  Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency.

Authors:  Markus Wolschek; Elisabeth Samm; Helena Seper; Sanda Sturlan; Irina Kuznetsova; Cornelia Schwager; Alexandra Khassidov; Christian Kittel; Thomas Muster; Andrej Egorov; Michael Bergmann
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

8.  Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles.

Authors:  Urtzi Garaigorta; Ana M Falcón; Juan Ortín
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

9.  Genetic analysis of nonstructural genes (NS1 and NS2) of H9N2 and H5N1 viruses recently isolated in Israel.

Authors:  Caroline Banet-Noach; Alexander Panshin; Natalia Golender; Lubov Simanov; Ezra Rozenblut; Shimon Pokamunski; Michael Pirak; Yevgenii Tendler; Maricarmen García; Boris Gelman; Ruslan Pasternak; Shimon Perk
Journal:  Virus Genes       Date:  2006-12-15       Impact factor: 2.332

10.  Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells.

Authors:  E Hatada; S Saito; R Fukuda
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.